<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on February 03, 2023</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00004296</url>
  </required_header>
  <id_info>
    <org_study_id>199/11731</org_study_id>
    <secondary_id>UNCCH-939</secondary_id>
    <nct_id>NCT00004296</nct_id>
  </id_info>
  <brief_title>Multicenter Study of Nontuberculous Mycobacteria in Cystic Fibrosis Patients</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>National Center for Research Resources (NCRR)</agency>
      <agency_class>NIH</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>University of North Carolina</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Office of Rare Diseases (ORD)</source>
  <brief_summary>
    <textblock>
      OBJECTIVES: I. Determine the prevalence of nontuberculous mycobacteria in sputum cultures&#xD;
      from patients with cystic fibrosis.&#xD;
&#xD;
      II. Compare the clinical course of patients with negative versus positive cultures.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      PROTOCOL OUTLINE: Participants are screened for nontuberculous mycobacteria (NTM) with 3&#xD;
      sputum acid-fast bacilli smears and mycobacterial cultures, with speciation of positive&#xD;
      cultures, collected over 1 year. Demographic data, diagnostic criteria, clinical&#xD;
      measurements, and other respiratory pathogen data are collected using the Cystic Fibrosis&#xD;
      Foundation Patient Registry Questionnaire.&#xD;
&#xD;
      NTM-positive patients (cases) matched with NTM-negative controls identified in screening are&#xD;
      followed every 3 months for 15 months. Cases are evaluated for NTM burden during the first 3&#xD;
      months.&#xD;
&#xD;
      Appropriate therapy is offered to consistently NTM-positive cases. Lung transplant recipients&#xD;
      are removed from study.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>September 1995</start_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <time_perspective>Other</time_perspective>
  </study_design_info>
  <enrollment>1000</enrollment>
  <condition>Cystic Fibrosis</condition>
  <condition>Atypical Mycobacterium Infection</condition>
  <eligibility>
    <criteria>
      <textblock>
        PROTOCOL ENTRY CRITERIA:&#xD;
&#xD;
        Patients over age 10 with cystic fibrosis documented as follows:&#xD;
&#xD;
          -  Pilocarpine sweat chloride test at least 60 mEq/L OR&#xD;
&#xD;
          -  Genotyping or transepithelial potential difference AND&#xD;
&#xD;
          -  Clinical symptoms of suppurative respiratory disease or pancreatic insufficiency&#xD;
&#xD;
        Able to produce at least 3 sputum samples&#xD;
&#xD;
          -  Bronchoscopy specimens acceptable&#xD;
&#xD;
          -  Throat/nasal specimens not acceptable&#xD;
&#xD;
        No Pseudomonas cepacia colonization&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>10 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ken Olivier</last_name>
    <role>Study Chair</role>
    <affiliation>University of North Carolina</affiliation>
  </overall_official>
  <reference>
    <citation>Whittier S, Olivier K, Gilligan P, Knowles M, Della-Latta P. Proficiency testing of clinical microbiology laboratories using modified decontamination procedures for detection of nontuberculous mycobacteria in sputum samples from cystic fibrosis patients. The Nontuberculous Mycobacteria in Cystic Fibrosis Study Group. J Clin Microbiol. 1997 Oct;35(10):2706-8. doi: 10.1128/jcm.35.10.2706-2708.1997.</citation>
    <PMID>9316943</PMID>
  </reference>
  <reference>
    <citation>Olivier KN.: Collaborative CFF/NCRR study of the epidemiology of nontuberculous mycobacteria in cystic fibrosis. Pediatric Pulmonology Suppl. 19: 145-146, 1999.</citation>
  </reference>
  <verification_date>January 2000</verification_date>
  <study_first_submitted>October 18, 1999</study_first_submitted>
  <study_first_submitted_qc>October 18, 1999</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 19, 1999</study_first_posted>
  <last_update_submitted>June 23, 2005</last_update_submitted>
  <last_update_submitted_qc>June 23, 2005</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 24, 2005</last_update_posted>
  <keyword>atypical mycobacterium infection</keyword>
  <keyword>bacterial infection</keyword>
  <keyword>cardiovascular and respiratory diseases</keyword>
  <keyword>cystic fibrosis</keyword>
  <keyword>genetic diseases and dysmorphic syndromes</keyword>
  <keyword>immunologic disorders and infectious disorders</keyword>
  <keyword>mycobacterium infection</keyword>
  <keyword>rare disease</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Infections</mesh_term>
    <mesh_term>Mycobacterium Infections</mesh_term>
    <mesh_term>Mycobacterium Infections, Nontuberculous</mesh_term>
    <mesh_term>Cystic Fibrosis</mesh_term>
    <mesh_term>Fibrosis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

